Real-time enrollment status for this primary sjogren's disease clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:36 PM UTC
| NCT Number | NCT07404865 |
| Recruiting Status | Recruiting |
| Condition | Primary Sjogren's Disease |
| Phase | PHASE3 |
| Target Enrollment | 250 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Vor Biopharma |
| Last Updated on CT.gov | August 27, 2026 (Aug 27, 2026) |
As of October 12, 2026: Clinical trial NCT07404865 is currently recruiting participants. This phase3 study for primary sjogren's disease is actively seeking new participants at 43 locations across the United States. The study is sponsored by Vor Biopharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07404865 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07404865 was last updated Aug 27, 2026 (August 27, 2026). HelloStudys verifies this status automatically.